Managing Neurotrophic Keratitis | ASCRS
Dr. at a computer
2020 ASCRS Virtual Annual Meeting

Virtual Meeting CME Activities

<< Back to Online CME Activites 

Managing Neurotrophic Keratitis

Available Online Now

This session will use an interactive case-based approach to present various clinical presentations of neurotrophic keratitis, review risk factors for Neurotrophic Keratitis, and discuss how to diagnose and review updated management protocols.

This activity is approved for 1.0 AMA PRA Category 1 Credit™.

This module is available to registrants of the 2020 ASCRS Virtual Annual Meeting. Log in using the teal button at the top right of the page to access this module.
ASCRS gratefully acknowledges the unrestricted educational grants received in support of the 2020 ASCRS Virtual Annual Meeting and Bonus CME Enduring Activities from:

Alcon Vision, LLC
Bausch + Lomb
Carl Zeiss Meditec
EyePoint Pharmaceuticals, Inc.
Omeros Corporation

Faculty

Marjan Farid, MD

Moderator

Kenneth Beckman, MD

Panelist

Francis Mah, MD

Panelist

Karolinne Rocha, MD

Panelist

Activity Agenda

Expand each item to view the topic and speaker details.

Educational Objectives

  • Describe the stages and presentations of neurotrophic keratitis
  • Recognize the various potential causes and risk factors of neurotrophic keratitis
  • Understand mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis
  • Identify the relationships between disease characteristics and treatment options
Introduction

Speaker
Marjan Farid, MD

Case Presentation #1: Easy Diagnosis

Speaker
Francis Mah, MD

Case Presentation #2: Stage 2 NK

Speaker
Francis Mah, MD

Serum/AMT/CTL Discussion

Panelists
Marjan Farid, MD, Francis Mah, MD, Kenneth Beckman, MD, and Karolinne Rocha, MD

Case Presentation #3: Neurotrophic Ulcer

Speaker
Karolinne Rocha, MD

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.